News
Weight-loss drugs are already dropping in price; could they go even lower? - Consumers are now able to pay roughly $500 for ...
Weight loss drugs like Wegovy and Zepbound are getting cheaper, if you are willing to pay out of pocket for the medications.
A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...
Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...
More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results